Bringing the covalency field under one roof for the first time, the inaugural Covalent Drug Discovery Summit comes to Boston this December – gathering 80+ covalent drug specialists from the likes of Amgen, Revolution Medicines, Novartis, Totus Medicines, Covant Therapeutics and more.

This is a unique opportunity to network with an audience of CXOs, VPs, Directors and Heads of Discovery, Medicinal and Biological Chemistry focused on covalent drug discovery.

Hear from 20+ industry leaders across three days of carefully curated content, engage in dedicated networking time with the field, ask your burning questions to our expert speakers at the end of each presentation, and dive deep into two interactive workshops on toxicity and safety concerns and the future of covalency.

Download your copy of the program here to find out more: https://ter.li/z6hwj6